International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: Opportunities and Challenges. - Chan, Andrew; Alroughani, Raed; Calabrese, Massimiliano; Havrdová, Eva Kubala; Obeidat, Ahmed Z.; Schmierer, Klaus; Andersson, Magnus; Bek, Louise; Savarin, Carine; Korich, Julie; Bonsignore, Luca; de Seze, Jérôme (Neurology & Therapy, 2026)